PE HUB Healthcare Wire Highlights, 5.17.18

Pamplona Capital, private equity, healthcare,
Sarah Pringle of Buyouts. Photo by Robert Daniel, Buyouts.

Pamplona loses healthcare executive, Sponsors chase opportunities in ENT


Those almost-summer showers have become pretty consistent in NYC, but lucky for me, the healthcare private equity community hasn’t gone on break quite yet.

I learned about one big people move this week. Jeremy Gelber, a partner at Pamplona Capital Management for some five years, has left the firm to take charge of healthcare investing efforts at Centerbridge Partnersaccording to people familiar with the matter.

And Gelber isn’t the first healthcare-focused investment professional to leave the PE firm. Michael Vaupen, a director at Pamplona for almost five years, joined Welsh, Carson, Anderson & Stowe in April, his LinkedIn profile shows.

The departures aren’t unique to healthcare. Pamplona founding member and Partner David Lang, who focused on a range of sectors including consumer, industrials and infrastructure, joined KKR in January.

While it remains unclear why Gelber and the others left, the timing is certainly interesting. It was just last summer that the sponsor’s fifth fund collected $3.2 billion. And the firm was behind one of 2017’s more high-profile transactions in healthcare generally speaking. That is, the $4.5 billion take-private of contract research organization Parexel.

If you’ve heard anything as it relates, give me a shout at


SUBSCRIBE to get the  Healthcare Wire in your inbox every Thursday morning. It’s free!